Identification of a Cullin5-Elonginb-Elonginc E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12482-12491

  Wang, Jiawen ^a   Zhang, Wenyan ^a   Lv, Mingyu ^a   Zuo, Tao ^a   Kong, Wei ^a   Yu, Xianghui ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; CULLIN; CULLIN 5; ELONGIN B; ELONGIN C; HYDROLASE; PROTEASOME; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIF PROTEIN; ZINC BINDING PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CAT; COMPLEX FORMATION; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; HYDROPHILICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN MOTIF;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CATS; CELLS, CULTURED; CULLIN PROTEINS; CYTOSINE DEAMINASE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, VIF; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

FELIDAE; FELINE FOAMY VIRUS; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS;

EID: 81255200313     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05218-11     Document Type: Article

References (63)

1. Bergeron, J. R., et al. 2010. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog. 6:e1000925.
2. Bieniasz, P. D. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109-1115.
3. Bogerd, H. P., H. L. Wiegand, B. P. Doehle, K. K. Lueders, and B. R. Cullen. 2006. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 34:89-95.
4. Cen, S., et al. 2004. The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 279:33177-33184.
5. Chen, G., Z. He, T. Wang, R. Xu, and X. F. Yu. 2009. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J. Virol. 83:8674-8682.
6. Dang, Y., R. W. Davis, I. A. York, and Y. H. Zheng. 2010. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity. J. Virol. 84:5741-5750.
7. Dang, Y., et al. 2008. Human cytidine deaminase APOBEC3H restricts HIV-1 replication. J. Biol. Chem. 283:11606-11614.
8. Dang, Y., X. Wang, W. J. Esselman, and Y. H. Zheng. 2006. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80:10522-10533.
9. Dang, Y., X. Wang, I. A. York, and Y. H. Zheng. 2010. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J. Virol. 84:8561-8570.
10. Dang, Y., X. Wang, T. Zhou, I. A. York, and Y. H. Zheng. 2009. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization. J. Virol. 83:8544-8552.
11. Esnault, C., et al. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433:430-433.
12. Fisher, A. G., et al. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
13. Goila-Gaur, R., and K. Strebel. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51.
14. Harris, R. S., et al. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
15. Harris, R. S., and M. T. Liddament. 2004. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4:868-877.
16. Hartikka, J., et al. 1996. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7:1205-1217.
17. He, Z., W. Zhang, G. Chen, R. Xu, and X. F. Yu. 2008. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J. Mol. Biol. 381:1000-1011.
18. Hori, T., et al. 1999. Covalent modification of all members of human Cullin family proteins by NEDD8. Oncogene 18:6829-6834.
19. Izumi, T., et al. 2009. MDM2 is a novel E3 ligase for HIV-1 Vif. Retrovirology 6:1.
20. Jonsson, S. R., et al. 2007. The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS One 2:e893.
21. Kamura, T., et al. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18:3055-3065.
22. LaRue, R. S., et al. 2009. Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 83:494-497.
23. Larue, R. S., J. Lengyel, S. R. Jonsson, V. Andresdottir, and R. S. Harris. 2010. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J. Virol. 84:8193-8201.
24. Lecossier, D., F. Bouchonnet, F. Clavel, and A. J. Hance. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112.
25. Lee, J., et al. 2011. Repression of porcine endogenous retrovirus infection by human APOBEC3 proteins. Biochem. Biophys. Res. Commun. 407:266-270.
26. Lee, T. H., et al. 1986. A new HTLV-1II/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546-1549.
27. Liddament, M. T., W. L. Brown, A. J. Schumacher, and R. S. Harris. 2004. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14:1385-1391.
28. Lochelt, M., et al. 2005. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U. S. A. 102:7982-7987.
29. Luo, K., et al. 2007. Adenovirus E4orf6 assembles with Cullin5-ElonginBElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21:1742-1750.
30. Luo, K., et al. 2005. Primate lentiviral virion infectivity factors are substrate receptors that assemble with Cullin5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc. Natl. Acad. Sci. U. S. A. 102:11444-11449.
31. Lv, M., et al. 2011. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity. PLoS One 6:e20890.
32. Mahrour, N., et al. 2008. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BCbased ubiquitin ligases. J. Biol. Chem. 283:8005-8013.
33. Marin, M., K. M. Rose, S. L. Kozak, and D. Kabat. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-1403.
34. Mehle, A., J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda. 2004. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18: 2861-2866.
35. Mehle, A., et al. 2004. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279:7792-7798.
36. Mehle, A., E. R. Thomas, K. S. Rajendran, and D. Gabuzda. 2006. A zincbinding region in Vif binds Cul5 and determines cullin selection. J. Biol. Chem. 281:17259-17265.
37. Munk, C., et al. 2008. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9:R48.
38. Munk, C., T. Hechler, S. Chareza, and M. Lochelt. 2010. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5α proteins. Vet. Immunol. Immunopathol. 134:14-24.
39. Pan, Z. Q., A. Kentsis, D. C. Dias, K. Yamoah, and K. Wu. 2004. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23:1985-1997.
40. Pery, E., K. S. Rajendran, A. J. Brazier, and D. Gabuzda. 2009. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J. Virol. 83:2374-2381.
41. Read, M. A., et al. 2000. Nedd8 modification of cul-1 activates SCF(β(TrCP))-dependent ubiquitination of I Bα. Mol. Cell. Biol. 20:2326-2333.
42. Russell, R. A., and V. K. Pathak. 2007. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J. Virol. 81:8201-8210.
43. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
44. Sheehy, A. M., N. C. Gaddis, and M. H. Malim. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:1404-1407.
45. Stanley, B. J., et al. 2008. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J. Virol. 82:8656-8663.
46. Stebbins, C. E., W. G. Kaelin, Jr., and N. P. Pavletich. 1999. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455-461.
47. Stern, M. A., et al. 2010. Productive replication of Vif-chimeric HIV-1 in feline cells. J. Virol. 84:7378-7395.
48. Strebel, K., et al. 1987. The HIV "A" (sor) gene product is essential for virus infectivity. Nature 328:728-730.
49. Svarovskaia, E. S., et al. 2004. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J. Biol. Chem. 279:35822-35828.
50. Turelli, P., B. Mangeat, S. Jost, S. Vianin, and D. Trono. 2004. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303:1829.
51. Walker, R. C., Jr., et al. 2010. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif. J. Virol. 84:5201-5211.
52. Wolfe, L. S., B. J. Stanley, C. Liu, W. K. Eliason, and Y. Xiong. 2010. Dissection of the HIV Vif interaction with human E3 ubiquitin ligase. J. Virol. 84:7135-7139.
53. Xiao, Z., E. Ehrlich, K. Luo, Y. Xiong, and X. F. Yu. 2007. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J. 21:217-222.
54. Xiao, Z., et al. 2006. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349:290-299.
55. Xu, R., et al. 2007. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology 46:1810-1820.
56. Yang, S., Y. Sun, and H. Zhang. 2001. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J. Biol. Chem. 276:4889-4893.
57. Yu, Q., et al. 2004. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11: 435-442.
58. Yu, X., et al. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060.
59. Yu, X. F. 2006. Innate cellular defenses of APOBEC3 cytidine deaminases and viral counter-defenses. Curr. Opin. HIV AIDS 1:187-193.
60. Yu, Y., Z. Xiao, E. S. Ehrlich, X. Yu, and X. F. Yu. 2004. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18:2867-2872.
61. Zhang, W., G. Chen, A. M. Niewiadomska, R. Xu, and X. F. Yu. 2008. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host antiviral proteins. PLoS One 3:e3963.
62. Zhang, W., et al. 2008. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases. Cell Microbiol. 10:1662-1675.
63. Zielonka, J., et al. 2010. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 84:7312-7324.